Clinical Trials
16 trialsNCT06801405 2026-05-19
Antibiotic Prophylaxis in Percutaneous Nephrostomy Placements and Replacements for Malignant Urinary Tract Obstruction
Barretos Cancer Hospital
Completed
NCT06549634 2026-02-27
Biomarkers of AKI in Patients Receiving Daratumumab
Brigham and Women's Hospital
Completed
NCT07114276 2026-01-09
Prospective Validation of Machine Learning Model to Predict Platinum Induced Nephrotoxicity in Cancer Patients
Taipei Medical University
Completed
NCT02358980 2025-06-25
KEEPER
Azienda USL Reggio Emilia - IRCCS
Completed
NCT04151264 2025-03-30
Influence of the "Hypotension Probability Index" on Intraoperative and Postoperative Hypotension in ENT- and OM-Surgery
University of Giessen
Phase NA Completed
NCT00120263 2025-03-25
Trial of Plasma Exchange for Acute Renal Failure at the Onset of Myeloma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase NA Completed
NCT06775158 2025-01-14
Perioperative Myocardial and Renal Injury in Patients Undergoing Hepatic Resection
Istanbul Saglik Bilimleri University
Completed
NCT06697613 2024-11-20
Development and Validation of a Prediction Model for AKI Following Cisplatin-Based HIPEC in Patients With Ovarian Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Completed
NCT04594161 2024-02-28
STONE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT06101498 2023-11-27
Peroperative Fluid Management in Major Gynecological Cancer Surgeries
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Phase NA Completed
NCT04755452 2023-06-22
The Effect of Pneumoperitoneum (Raised Pressure in the Peritoneal Cavity) During Robotic Kidney/Prostate Cancer Surgery.
Aalborg University Hospital
Phase NA Completed
NCT04773080 2023-02-28
Incidence, Risk Factors and Consequences of Acute Kidney Injury in Patients Undergoing Esophageal Cancer Surgery
Azienda Ospedaliera di Padova
Completed
NCT02921828 2022-07-05
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
Completed
NCT05407272 2022-06-08
Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care
National Taipei University of Nursing and Health Sciences
Phase NA Completed
NCT03273751 2021-10-21
The Effect of Remote Ischemic Preconditioning on Kidney Function in Patients Undergoing Partial Nephrectomy
Seoul National University Hospital
Phase NA Completed
NCT04341974 2020-04-14
CreaPeriop
Careggi Hospital
Completed